Evidence map›Paper›PMID 31183318›Full record

ArticleAnalytical cellular pathology (Amsterdam)2019

The Laminin-

Madhavi Puchalapalli, Liang Mu, Chevaunne Edwards, Benjamin Kaplan-Singer, Pearl Eni, Kiran Belani, David Finkelstein, Arpan Patel, Megan Sayyad, Jennifer E Koblinski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Analytical cellular pathology (Amsterdam), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Current preclinical models of brain metastasis.Clinical & experimental metastasis · 2024
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Madhavi PuchalapalliDepartment of Pathology, Virginia Commonwealth University, School of Medicine, Massey Cancer Institute, Richmond, VA, USA.
Liang MuDepartment of Pathology, Women's Cancer Research Program, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Institute, Northwestern University, Chicago, IL, USA.
Chevaunne EdwardsDepartment of Pathology, Virginia Commonwealth University, School of Medicine, Massey Cancer Institute, Richmond, VA, USA.ORCID 0000-0002-2373-1135
Benjamin Kaplan-SingerCraniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Pearl EniDepartment of Pathology, Women's Cancer Research Program, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Institute, Northwestern University, Chicago, IL, USA.
Kiran BelaniCraniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
David FinkelsteinDepartment of Pathology, Women's Cancer Research Program, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Institute, Northwestern University, Chicago, IL, USA.
Arpan PatelDepartment of Pathology, Women's Cancer Research Program, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Institute, Northwestern University, Chicago, IL, USA.ORCID 0000-0001-5863-2180
Megan SayyadDepartment of Pathology, Virginia Commonwealth University, School of Medicine, Massey Cancer Institute, Richmond, VA, USA.ORCID 0000-0002-8893-6043
Jennifer E KoblinskiDepartment of Pathology, Virginia Commonwealth University, School of Medicine, Massey Cancer Institute, Richmond, VA, USA.ORCID 0000-0002-7156-2030
Northwestern University · USVirginia Commonwealth University · USNational Institutes of Health · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
A laminin peptide increases breast cancer bone metastasisK22CA116258 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KOBLINSKI, JENNIFER E · 2007 to 2009
$459k
NCI NIH HHS K22 CA116258NCI NIH HHS P30 CA060553
6 · The paper itself

Abstract

Breast cancer is one of the most common forms of cancer affecting women in the United States, second only to skin cancers. Although treatments have been developed to combat primary breast cancer, metastasis remains a leading cause of death. An early step of metastasis is cancer cell invasion through the basement membrane. However, this process is not yet well understood. AG73, a synthetic laminin-

Indexed as

Breast NeoplasmsCell Line, TumorFemaleHumansLamininNeoplasm InvasivenessNeoplasm MetastasisPeptidesProtein BindingSyndecan-1Syndecan-2Lamininlaminin APeptidesSyndecan-1Syndecan-2

Identifiers

PMID31183318
PMCPMC6515157
OpenAlexW2942998119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.